Metastatic HER2 positive breast cancer - lapatinib - initial authority application form (PB099)

Use this form to apply for initial PBS-subsidised treatment with lapatinib for HER2 positive metastatic breast cancer.

Page last updated: 1 September 2024.
QC 21116